Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by Vinny57on Mar 03, 2020 2:42pm
258 Views
Post# 30762208

RE:RE:RE:RE:RE:100 million was by Spartan fund and MMCAP

RE:RE:RE:RE:RE:100 million was by Spartan fund and MMCAP
Daredevil1964 wrote: You are missing the point. It was led to believe that an injection of 100 million was from a bonfied Investor. Example Bayer or Nestle. This is not a bonfied investment. The share price certainly reflects this is not a bonifed investor. Since the announcement of the 100 million investment APHA has lost roughly 40% of SP. Not to mention a loss of 500 million US in market cap.  Does that not tell you that there is something wrong with this deal. Shorting has increased at higher lending rates. The market's do not like this deal, because APHA has been down nearly 80% of the trading days since it was announced.



For some reason there are people on this site who do not want to face the facts. DD 64, you are 100% correct in your post.  While the CV 'flu' and systemic market sentiment is a factor in the drop in share price, it is mainly due to what is contained in your post. This is yet another hurdle we need to overcome.   Perhaps one day, luck and momentum will change.

We are long overdue.
Bullboard Posts